ROCKVILLE, Md. and SHANGHAI, Aug. 16, 2026 /PRNewswire/ — AbelZeta Pharma, Inc. (“AbelZeta” or the “Company”), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced that the…
SAN FRANCISCO and SUZHOU, China, Aug. 5, 2026 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and…
Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen listed on the Pharmaceutical Benefits Scheme (PBS) for adults with relapsed or refractory follicular lymphoma (R/R FL)…
In the news release, Biotech Innovator InstaMed® Pharmaceuticals Appoints Tracy Gibbs, PhD, as Chief Executive Officer Ahead of Worldwide Launch of Non-Injectable Peptide Platform, issued 27-Jul-2026 by InstaMed® Pharmaceuticals over PR Newswire, we are advised by the company…
Buying a home is a major financial decision, and in Argentina, it comes with unique challenges—especially for those looking to
Over the weekend, thousands of people took to the streets in several cities across Argentina to protest the brutal murder
